Authors
Loading...
This immune engineering study demonstrates effective gene editing using gold nanoparticles to deliver CRISPR components into primary blood cells, implying advancements in gene therapy.
Cunningham et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: